Research Alliance Corp V

What the company does

Research Alliance Corporation V is a newly organized blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It has not selected any specific business combination target or initiated substantive discussions regarding a potential target.

Use of proceeds

Of the proceeds we receive from this offering and the sale of the private placement shares described in this prospectus, $62,000,000 ($10.00 per share), will be deposited into a trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee. Upon consummation of this offering, we will repay up to $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses.

Underwriters

Extracted from S-1 0001193125-26-452284, filed Nov 9, 2026 and verified against that filing text.

Key risk factors

• No business combination target

  “We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.”

• No warrants

  “Unlike many other initial public offerings of special purpose acquisition companies (“SPAC IPOs”), investors in this offering will not receive warrants that would become exercisable following completion of our initial business combination.”

• Listing uncertainty

  “We cannot guarantee that our securities will be approved for listing on Nasdaq.”

• Conflict of interest

  “Our sponsor and members of our management team will directly or indirectly own our securities following this offering, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.”

• Incentive to complete transaction

  “If we are unable to complete our initial business combination within 24 months from the closing of this offering, or by such earlier liquidation date as our board of directors may approve, the founder shares and private placement shares will be worthless, which could create an incentive for our sponsor and members of our management team to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders.”

• Additional obligations to other entities

  “Additionally, each of our officers and directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entities.”

• Founder share dilution

  “Our sponsor contributed $25,000, or approximately $0.02 per founder share, and, accordingly, you will experience immediate and material dilution from the purchase of our ordinary shares.”